These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33281164)

  • 1. Short-term Effects of Hepatic Arterial Buffer Responses Induced by Partial Splenic Embolization on the Hepatic Function of Patients with Cirrhosis According to the Child-Pugh Classification.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    Intern Med; 2021 May; 60(9):1331-1342. PubMed ID: 33281164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.
    Ishikawa T; Sasaki R; Nishimura T; Aibe Y; Saeki I; Iwamoto T; Hidaka I; Takami T; Sakaida I
    PLoS One; 2019; 14(9):e0223153. PubMed ID: 31557230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications.
    Cai M; Huang W; Lin C; Li Z; Qian J; Huang M; Zeng Z; Huang J; Shan H; Zhu K
    Eur Radiol; 2016 Feb; 26(2):370-80. PubMed ID: 26002134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal and splanchnic hemodynamics after partial splenic embolization in cirrhotic patients with hypersplenism.
    Helaly AZ; Al-Warraky MS; El-Azab GI; Kohla MA; Abdelaal EE
    APMIS; 2015 Dec; 123(12):1032-9. PubMed ID: 26547369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Portal venous blood flow velocity is a factor associated with portal venous thrombosis after partial splenic artery embolization in hepatic cirrhosis patients.
    Huang J; Liu H
    Ann Med Surg (Lond); 2024 Feb; 86(2):650-654. PubMed ID: 38333286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for complications after partial splenic embolization for liver cirrhosis.
    Hayashi H; Beppu T; Okabe K; Masuda T; Okabe H; Baba H
    Br J Surg; 2008 Jun; 95(6):744-50. PubMed ID: 18412294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
    Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
    Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term portal hemodynamic effects of partial splenic embolization for hypersplenism.
    Chikamori F; Kuniyoshi N; Kawashima T; Takase Y
    Hepatogastroenterology; 2007 Sep; 54(78):1847-9. PubMed ID: 18019732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenic non-infarction volume determines a clinically significant hepatic venous pressure gradient response to partial splenic embolization in patients with cirrhosis and hypersplenism.
    Ishikawa T; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Saeki I; Hidaka I; Takami T; Sakaida I
    J Gastroenterol; 2021 Apr; 56(4):382-394. PubMed ID: 33629147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Large splenic volume may be a useful predictor for partial splenic embolization-induced liver functional improvement in cirrhotic patients.
    Hayashi H; Beppu T; Masuda T; Okabe H; Imai K; Hashimoto D; Ikuta Y; Chikamoto A; Watanabe M; Baba H
    J Hepatobiliary Pancreat Sci; 2014 Jan; 21(1):51-7. PubMed ID: 23798315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications of partial splenic embolization in cirrhotic patients.
    Sakai T; Shiraki K; Inoue H; Sugimoto K; Ohmori S; Murata K; Takase K; Nakano T
    Dig Dis Sci; 2002 Feb; 47(2):388-91. PubMed ID: 11855556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Therapeutic Strategy Using Interventional Radiology (IVR) for Hepatitis C Virus (HCV)-Related Decompensated Liver Cirrhosis: A Case Report.
    Iwamoto T; Saeki I; Hidaka I; Ishikawa T; Takami T; Sakaida I
    Am J Case Rep; 2019 Nov; 20():1699-1704. PubMed ID: 31738743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.
    Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
    Hepatol Res; 2014 Oct; 44(11):1056-61. PubMed ID: 23941627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significant improvement in portal-systemic liver failure symptoms and successful management of portal-splenic venous hemodynamics by the combination of interventional radiology and pharmacotherapy.
    Ishikawa T; Hamamoto K; Sasaki R; Nishimura T; Matsuda T; Iwamoto T; Takami T; Sakaida I
    Hepatol Res; 2020 Oct; 50(10):1201-1208. PubMed ID: 32609922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role and evolution of partial splenic embolization over three decades: A multicentric retrospective single cohort study of 90 patients from French nationwide experience.
    Leideck P; Nkontchou G; Elkrief L; Erard D; d'Alteroche L; Radenne S; Billioud C; Meszaros M; Regnault D; Pageaux GP; Hilleret MN; Tripon S; Guillaud O; Ollivier-Hourmand I; Ganne-Carrié N; Dumortier J
    Clin Res Hepatol Gastroenterol; 2024 Jun; 48(6):102355. PubMed ID: 38679291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial splenic embolization for hypersplenism concomitant with or after arterial embolization of hepatocellular carcinoma in 30 patients.
    Han MJ; Zhao HG; Ren K; Zhao DC; Xu K; Zhang XT
    Cardiovasc Intervent Radiol; 1997; 20(2):125-7. PubMed ID: 9030503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of heparin plus dexamethasone after partial splenic embolization for liver cirrhosis with massive splenomegaly.
    Lu H; Zheng C; Xiong B; Xia X
    BMC Gastroenterol; 2022 Nov; 22(1):470. PubMed ID: 36402985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The evaluation of therapeutic effect on partial splenic embolization (PSE) for liver cirrhosis patients].
    Nishikubo H; Onda M; Tajiri T; Kim DY
    Nihon Shokakibyo Gakkai Zasshi; 1996 Jan; 93(1):19-25. PubMed ID: 8642754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in portal hemodynamics and hepatic function after partial splenic embolization (PSE) and percutaneous transhepatic obliteration (PTO).
    Mukaiya M; Hirata K; Yamashiro K; Katsuramaki T; Kimura H; Denno R
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S37-41. PubMed ID: 8137483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.